Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,591.90
(
0.54%
)
US TECH 100
23,318.40
(
-0.83%
)
Dow Jones
46,429.49
(
0.66%
)
Brent Oil
101.07
(
2.32%
)
Bitcoin
69,589.19
(
-2.40%
)
News Focus
News Focus
Post# of 257288
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

biocqr

Send PM Follow Ignore
Followers 50
Posts 3530
Boards Moderated 0
Alias Born 08/24/2005

biocqr

Member Level

Re: DewDiligence post# 224242

Friday, 09/20/2019 9:47:01 AM

Friday, September 20, 2019 9:47:01 AM

Post# of 257288
JNJ/Janssen RSV program...received a solicitation today to participate in this RSV vaccine P2 trial (5800 pts) which commenced Aug 1...

A Study of an Ad26.RSV.preF-based Regimen in the Prevention of Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)-Confirmed Respiratory Syncytial Virus (RSV)-Mediated Lower Respiratory Tract Disease in Adults Aged 65 Years and Older

https://clinicaltrials.gov/ct2/show/NCT03982199



Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now